Provided by Tiger Trade Technology Pte. Ltd.

Vanda Pharmaceuticals

4.99
-0.1600-3.11%
Post-market: 4.990.00000.00%19:30 EDT
Volume:758.87K
Turnover:3.79M
Market Cap:301.71M
PE:-1.08
High:5.17
Open:5.17
Low:4.96
Close:5.15
52wk High:9.94
52wk Low:4.27
Shares:60.46M
Float Shares:47.66M
Volume Ratio:1.00
T/O Rate:1.59%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.6291
EPS(LYR):-3.7413
ROE:-77.81%
ROA:-22.38%
PB:1.37
PE(LYR):-1.33

Loading ...

Vanda Pharmaceuticals Inc - Proposal Would Eliminate FDA 180-Day Nda Review Requirement

THOMSON REUTERS
·
Apr 09

Vanda Pharmaceuticals Calls on FDA to Withdraw Proposal From FY 2027 Legislative Agenda That Would Extend Drug Review Timelines

THOMSON REUTERS
·
Apr 09

Vanda Pharmaceuticals: Undervalued GLP-1 Adjunct Opportunity Driven by Tradipitant’s Pivotal Thetis Trial

TIPRANKS
·
Apr 09

Vanda starts Thetis trial of NEREUS to curb GLP-1 therapy vomiting

Reuters
·
Apr 09

Vanda Pharmaceuticals Announces Initiation of the Thetis Study, a Clinical Trial of Nereus™ for the Prevention of Vomiting Induced by Glp-1 Receptor Agonists

THOMSON REUTERS
·
Apr 09

Vanda Pharmaceuticals Inc - Topline Results From Thetis Study Expected by Q4 2026

THOMSON REUTERS
·
Apr 09

Vanda Pharmaceuticals Inc: Phase 2 Study Succeeded and Met Its Primary Endpoint

THOMSON REUTERS
·
Apr 09

Vanda SVP, General Counsel Timothy Williams resigns effective April 10

Reuters
·
Apr 03

Ema's Chmp: Confirmed Recommendation to Refuse a Change to Marketing Authorisation for Hetlioz (Tasimelteon)

THOMSON REUTERS
·
Mar 27

Vanda Pharmaceuticals Calls for FDA Action to Accelerate Shift From Animal Testing to Human-Relevant Methods

THOMSON REUTERS
·
Mar 20

Vanda Pharmaceuticals urges FDA to revise draft guidance on non-animal testing methods

Reuters
·
Mar 20

Ema: Refusal of Change to Hetlioz Marketing Authorisation to Add Treatment of Nighttime Sleep Disturbance in Adults With Smith-Magenis Syndrome

THOMSON REUTERS
·
Mar 18

Ema: Issued Its Opinion on Hetlioz Marketing Authorisation Change After Re-Examination on 16 March

THOMSON REUTERS
·
Mar 18